Journal of Clinical Microbiology · 2013 · 41 citations · 20 references
Veterinary MedicineInfectious DiseasesMolecular MedicineDiagnostic MicrobiologyMolecular DiagnosticsVirologyInfectious Disease DetectionPathogen DetectionRespiratory InfectionsRespiratory Infectious DiseasesRespiratory Tract InfectionsViral DiagnosticsDiagnostic Assay DevelopmentInfluenza DiagnosticsMolecular Respiratory Pathogen DetectionMultiplex Molecular DiagnosticsMultiplex Molecular TestingRespiratory Pathogen ScreeningRespiratory Pathogen TestingRespiratory Viruses
Respiratory tract infections (RTIs) are caused by a plethora of viral and bacterial pathogens. In particular, lower RTIs are a leading cause of hospitalization and mortality. Timely detection of the infecting respiratory pathogens is crucial to optimize treatment and care. In this study, three U.S. Food and Drug Administration-approved molecular multiplex platforms (Prodesse ProFLU+/FAST+, FilmArray RP, and Verigene RV+) were evaluated for influenza virus detection in 171 clinical samples collected during the Belgian 2011-2012 influenza season. Sampling was done using mid-turbinate flocked swabs, and the collected samples were stored in universal transport medium. The amount of viral RNA present in the swab samples ranged between 3.07 and 8.82 log10 copies/ml. Sixty samples were concordant influenza A virus positive, and 8 samples were found to be concordant influenza B virus positive. Other respiratory viruses that were detected included human rhinovirus/enterovirus, respiratory syncytial virus, parainfluenza virus type 1, human metapneumovirus, and coronavirus NL63. Twenty-five samples yielded discordant results across the various assays which required further characterization by sequencing. The FilmArray RP and Prodesse ProFLU+/FAST+ assays were convenient to perform with regard to sensitivity, ease of use, and low percentages of invalid results. Although the limit of sensitivity is of utmost importance, many other factors should be taken into account in selecting the most convenient molecular diagnostic assay for the detection of respiratory pathogens in clinical samples.
20
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert, Gira Bhabha, Marc‐André Elsliger et al. · Science · 2009 · 1.4K citations · Full text
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert, Robert H. Friesen, Gira Bhabha et al. · Science · 2011 · 861 citations